Brand name: Adynovate TM
Listen to the Pronunciation:
Active ingredients: rurioctocog alfa pegol
What it is used for
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White to off-white friable powder
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Injection, solution
Clear, colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 3: Injection, solution
Clear, colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Refrigerate
- Do not Freeze
- Shelf lifetime is 24 Months.
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is Not Scheduled.
Pregnant or planning a pregnancy?
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White to off-white friable powder
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Injection, solution
Clear, colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 3: Injection, solution
Clear, colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Refrigerate
- Do not Freeze
- Shelf lifetime is 24 Months.
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is Not Scheduled.
Pregnant or planning a pregnancy?
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White to off-white friable powder
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Injection, solution
Clear, colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 3: Injection, solution
Clear, colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Refrigerate
- Do not Freeze
- Shelf lifetime is 24 Months.
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is Not Scheduled.
Pregnant or planning a pregnancy?
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White to off-white friable powder
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Injection, solution
Clear, colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 3: Injection, solution
Clear, colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Refrigerate
- Do not Freeze
- Shelf lifetime is 24 Months.
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is Not Scheduled.
Pregnant or planning a pregnancy?
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White to off-white friable powder
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Injection, solution
Clear, colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 3: Injection, solution
Clear, colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Protect from Light
- Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is Not Scheduled.
Pregnant or planning a pregnancy?
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White to off-white friable powder
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Injection, solution
Clear, colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 3: Injection, solution
Clear, colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Protect from Light
- Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is Not Scheduled.
Pregnant or planning a pregnancy?
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White to off-white friable powder
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Injection, solution
Clear, colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 3: Injection, solution
Clear, colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Refrigerate
- Do not Freeze
- Shelf lifetime is 24 Months.
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is Not Scheduled.
Pregnant or planning a pregnancy?
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White to off-white friable powder
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Injection, solution
Clear colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 3: Injection, solution
Clear, colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Protect from Light
- Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is Not Scheduled.
Pregnant or planning a pregnancy?
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White to off-white friable powder
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Injection, solution
Clear colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Protect from Light
- Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is Not Scheduled.
Pregnant or planning a pregnancy?
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White to off-white friable powder
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Injection, solution
Clear colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 3: Injection, solution
Clear, colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Protect from Light
- Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is Not Scheduled.
Pregnant or planning a pregnancy?
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
ADYNOVATE is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia A (congenital factor VIII deficiency) patients for:, Control and prevention of bleeding episodes, Routine prophylaxis to prevent or reduce the frequency of bleeding episodes, Perioperative management (surgical prophylaxis),ADYNOVATE is not indicated for the treatment of von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White to off-white friable powder
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Injection, solution
Clear colourless solution
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Protect from Light
- Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is Not Scheduled.
Pregnant or planning a pregnancy?
For the active ingredient rurioctocog alfa pegol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
